Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I clinical trial of KSP-0576
jRCT2071250154Phase 1Recruiting
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of KSP-0576 in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoints: Incidence of adverse events and adverse drug reactions, Concentrations of KSP-0576 and 1 more. Started Apr 2026; status: recruiting.
02
Drugs
KSP-0576
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on jRCT2071250154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250154.